Spaulding Rehabilitation Hospital Boston is developing an exoskeleton training program for patients affected by spinal cord injuries (SCI) that will feature the ReWalk Robotics exoskeleton systems. As the program takes shape, Spaulding reports that its Select Spaulding Clinical Team has completed basic training on the ReWalk system, and is actively pursuing advanced certification.
Robert McCall, vice president inpatient rehabilitation, Spaulding Rehabilitation Network, says that incorporating the ReWalk device into the organization’s clinical pathways is an initiative that it is hoped will deliver great benefits to the communities the Spaulding serves. “At Spaulding, we are always pushing to merge the most innovative technologies with the care we provide,” McCall says.
A media release from Spaulding describes ReWalk as a wearable robotic exoskeleton designed to provide powered hip and knee motion that enables individuals with SCI to stand upright and walk. The system is also reported to provide user-initiated mobility through the integration of a wearable brace support, a computer-based control system, and motion sensors. The system aims to allow independent, controlled walking while mimicking the natural gait patterns of the legs.
The ReWalk system is also reported to have clearance from the US Food and Drug Administration. The company offers two exoskeleton models: one that will be utilized by Spaulding and one for use at home and throughout the community.
“Spaulding is home to one of the nation’s leading spinal cord injury centers, with a second-to-none reputation,” says ReWalk CEO Larry Jasinski. “ReWalk is proud to work with Spaulding to be a part of its cutting-edge services for SCI patients. We applaud Spaulding’s innovative approach to treatment, and look forward to bringing this technology to as many people as possible,” he adds.
[Source: Spaulding Rehabilitation Network]
